痤疮治疗市场：按药物类别、类型、适应症、配方、分销渠道、地区 - 规模、份额、展望、机会分析，2022-2030 年

痤疮是一种皮肤病，当髮根被皮脂和死皮细胞堵塞时就会发生。 结果是粉刺、黑头和白头。 儘管任何年龄的人都可能患上它，但痤疮在青少年中最为常见。 肿块和丘疹癒合缓慢，当一个癒合时，另一个会弹出。 根据痤疮的严重程度，它会在皮肤上留下疤痕并引起情绪困扰。 痤疮药物通过减少皮脂分泌、治疗细菌感染和消肿来发挥作用。 健康皮肤的皮脂腺分泌的皮脂通过毛孔、毛囊的开口释放到皮肤表面。 毛囊内衬有角质形成细胞，一种皮肤细胞。 当皮肤细胞脱落时，这些角质形成细胞通常会上升到皮肤表面。 毛髮、皮脂和角质形成细胞聚集在痤疮患者的毛孔中。 结果，角质细胞不会脱落，皮脂也不会渗入皮肤表面。 炎症，如肿胀、发红、发热和疼痛，是由通常存在于皮肤中的细菌在被油脂和细胞堵塞的毛囊中繁殖引起的。

市场动态

产品等市场主要参与者越来越多地采用无机策略，预计这将在预测期内推动市场增长。 例如，製药公司 Galderma 于 2022 年 3 月 25 日至 29 日在马萨诸塞州波士顿举行的美国皮肤病学会 (AAD) 年会上宣布，“TWYNEO（维甲酸和过氧化苯甲□）乳膏，0.1%/3%”将在美国上映。 TWYNEO 霜是第一个也是唯一一个含有 0□□.1% 维甲酸和 3% 过氧化苯甲□ (BPO) 的二合一配方，被证明对中度至重度面部痤疮有效，并且已经过疗效测试。

这项研究的主要特点

• 本报告对全球痤疮药物市场进行了深入分析，说明了以 2021 年为基准年的预测期（2022-2030 年）的市场规模和復合年增长率 (CAGR%) 的增长。
• 解释了不同细分市场的潜在创收机会，并描述了针对该市场的有吸引力的投资建议矩阵。
• 它还提供了有关市场驱动因素、制约因素、机会、新产品发布或批准、市场趋势、区域前景、主要参与者采用的竞争战略等方面的重要见解。
• 它根据以下参数介绍了全球痤疮治疗市场的主要参与者：公司亮点、产品组合、主要亮点、财务业绩和战略。
• 本研究涉及的主要公司包括 Galderma Laboratories, L.P、Reckitt Benckiser Group PLC.、Bausch Health Companies Inc.、GlaxoSmithKline plc.、Arctic Therapeutics International、Mylan N.V.、Sun Pharmaceutical Industries Ltd.、AbbVie Inc.、 Biopharmx, Inc.、Paratek Pharmaceuticals, Inc.、Teva Pharmaceutical Industries Ltd.、Johnson & Johnson、F. Hoffmann-La Roche Ltd
• 这份报告中的见解将使营销人员和企业高管能够就他们未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。我认为我们可以。
• 《全球痤疮治疗药物市场》报告面向该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和金融分析师。
• 利益相关者可以通过用于分析全球痤疮治疗市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第2章市场展望

• 报告内容
  • 市场定义和范围
• 执行摘要
  • 市场概况：按药物类别
  • 市场概况：按类型分类
  • 市场概况：按指示
  • 按配方分类的市场概况
  • 市场概况：按销售渠道
  • 市场概况：按地区
• 连贯机会图 (COM)

第3章市场动态、规律及趋势分析

• 市场动态
  • 司机
  • 约束因素
  • 市场机会
• 影响分析
• 治疗概述
  • 治疗方法：按年龄
  • 按性别分类的疗法
• 管道分析
• 监管场景
• 市场趋势
• 最近的产品批准/发布
• 害虫分析
• 主要发展状况
• 流行病学
• 品牌分析

第 4 章全球痤疮药物市场-冠状病毒 (COVID-19) 大流行的影响

• 经济影响
• COVID-19 的流行病学特征
• 对全球痤疮治疗药物市场的总体影响

第 5 章全球痤疮药物市场：按药物类别，2017-2030

• 维甲酸
• 外用维甲酸
• 口服维甲酸
• 抗生素
• 抗生素（外用
• 口服抗生素
• 组合
• 克林霉素 + 过氧化苯甲□
• 克林霉素 + 维甲酸
• 阿达帕林 + 过氧化苯甲□
• 维甲酸 + 过氧化苯甲□
• 其他
• 水杨酸
• 壬二酸
• 过氧化苯甲□
• 其他

第 6 章全球痤疮治疗市场类型，2017-2030

• 处方药
• 场外交易

第 7 章。全球痤疮药物市场：按适应症分类，2017-2030

• 炎症性痤疮
• 非炎症性痤疮

第 8 章全球痤疮药物市场：按配方分类，2017-2030

• 外科学
• 口腔医学

第 9 章。全球痤疮药物市场：按分销渠道，2017-2030

• 医院药房
• 零售药房
• 在线药店

第 10 章全球痤疮治疗药物市场，按地区划分，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲地区
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海湾合作委员会
• 以色列
• 其他中东地区
• 非洲
• 北非
• 中非
• 南非

第11章竞争格局

• Galderma Laboratories, L.P.
• Reckitt Benckiser Group PLC.
• Bausch Health Companies Inc.
• GlaxoSmithKline plc.
• Arctic Therapeutics International
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Biopharmx, Inc.
• Paratek Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd

第12章章节

• 调查方法
• 关于出版商

Acne is a skin condition that occurs when your hair follicles become plugged with oil and dead skin cells. It results in pimples, blackheads, or whiteheads. Although, it can afflict anyone at any age, acne is most prevalent in teenagers. The lumps and pimples heal slowly, and just as one starts to go, another one seems to appear. Depending on how severe it is, acne can leave skin scars and create emotional distress. Acne treatments function by lowering sebum production, curing bacterial infections, and/or reducing swelling. Sebum produced by the sebaceous glands in healthy skin is released onto the skin's surface through the pore, a follicular opening. The follicle is lined with keratinocytes, a kind of skin cell. The keratinocytes normally ascend to the skin's surface during skin cell shedding. Hair, sebum, and keratinocytes clump together in the pore of an acne patient. As a result, the keratinocytes are kept from shedding and sebum is kept from penetrating the skin's surface. Inflammation, including swelling, redness, heat, and pain, is brought on by bacteria that ordinarily reside on the skin and can proliferate in clogged follicles when oil and cells are present.

Market Dynamics

Increasing adoption of inorganic strategies by key players in market such as product is expected to drive market growth over the forecast period. For instance, in March 2022, Galderma, a pharmaceutical company, announced the U.S. launch of TWYNEO (tretinoin and benzoyl peroxide) Cream, 0.1%/3%, during the American Academy of Dermatology (AAD) Annual Meeting, held during March 25-29, 2022, in Boston, Massachusetts. The first and only 0.1% tretinoin and 3% benzoyl peroxide (BPO) 2-in-1 formulation that has been shown to effectively treat moderate to severe face acne is TWYNEO Cream.

Key features of the study:

• This report provides an in-depth analysis of the global acne medication market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global acne medication market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Galderma Laboratories, L.P, Reckitt Benckiser Group PLC., Bausch Health Companies Inc., GlaxoSmithKline plc., Arctic Therapeutics International, Mylan N.V., Sun Pharmaceutical Industries Ltd., AbbVie Inc., Biopharmx, Inc., Paratek Pharmaceuticals, Inc., Teva Pharmaceutical Industries Ltd., Johnson & Johnson, F. Hoffmann-La Roche Ltd
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global acne medication market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global acne medication market

Detailed Segmentation:

• Global Acne Medication Market, By Drug Class:
  • Topical Retinoid
  • Oral Retinoid
  • Topical Antibiotics
  • Oral Antibiotics
  • Clindamycin + Benzoyl Peroxide
  • Clindamycin + Tretinoin
  • Adapalene + Benzoyl Peroxide
  • Tretinoin + Benzoyl Peroxide
  • Others
  • Retinoid
  • Antibiotics
  • Fixed Dose Combinations
  • Salicylic Acid
  • Azelaic Acid
  • Benzoyl Peroxide
  • Others
• Global Acne Medication Market, By Type:
  • Prescription
  • OTC
• Global Acne Medication Market, By Indication:
  • Inflammatory Acne
  • Non-Inflammatory Acne
• Global Acne Medication Market, By Formulation:
  • Topical Medication
  • Oral Medication
• Global Acne Medication Market, By Distribution Channel:
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
• Global Acne Medication Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Galderma Laboratories, L.P.*
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Reckitt Benckiser Group PLC.
  • Bausch Health Companies Inc.
  • GlaxoSmithKline plc.
  • Arctic Therapeutics International
  • Mylan N.V.
  • Sun Pharmaceutical Industries Ltd.
  • AbbVie Inc.
  • Biopharmx, Inc.
  • Paratek Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Johnson & Johnson
  • F.Hoffmann-La Roche Ltd

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Drug Class
  • Market Snapshot, By Type
  • Market Snapshot, By Indication
  • Market Snapshot, By Formulation
  • Market Snapshot, By Distribution Channel
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Treatment Overview
  • Treatment By Age
  • Treatment By Gender
• Pipeline Analysis
• Regulatory Scenario
• Market Trends
• Recent Product Approval/Launch
• PEST Analysis
• Key Developments
• Epidemiology
• Brand Analysis

4. Global Acne Medication Market- Impact of Coronavirus (Covid-19) Pandemic

• Economic Impact
• COVID-19 Epidemiology
• Overall impact on Global Acne Medication Market

5. Global Acne Medication Market, By Drug Class, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Retinoid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Topical Retinoid
• Oral Retinoid
• Antibiotics
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Topical Antibiotics
• Oral Antibiotics
• Fixed Dose Combinations
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Clindamycin + Benzoyl Peroxide
• Clindamycin + Tretinoin
• Adapalene + Benzoyl Peroxide
• Tretinoin + Benzoyl Peroxide
• Others
• Salicylic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Azelaic Acid
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Benzoyl Peroxide
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Others
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Acne Medication Market, By Type, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Prescription
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• OTC
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Acne Medication Market, By Indication, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Inflammatory Acne
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Non-Inflammatory Acne
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Acne Medication Market, By Formulation, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Topical Medication
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Oral Medication
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

9. Global Acne Medication Market, By Distribution Channel, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Hospital Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Retail Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Online Pharmacies
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

10. Global Acne Medication Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Drug Class, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Type, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Indication, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Formulation, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Distribution, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

11. Competitive Landscape

• Galderma Laboratories, L.P.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Reckitt Benckiser Group PLC.
• Bausch Health Companies Inc.
• GlaxoSmithKline plc.
• Arctic Therapeutics International
• Mylan N.V.
• Sun Pharmaceutical Industries Ltd.
• AbbVie Inc.
• Biopharmx, Inc.
• Paratek Pharmaceuticals, Inc.
• Teva Pharmaceutical Industries Ltd
• Johnson & Johnson
• F. Hoffmann-La Roche Ltd

12. Section

• Research Methodology
• About Us